Candidiasis orofaringea en pacientes con SIDA o con neoplasias experiencia interinstitucional con fluconazol en Colombia

Estrada, Santiago; González, Consuelo; Lobo Guerrero, Jose; Mendoza, Mario; Martínez, Gabriel; Orosco, Beatriz; Panesso, Roberto; Rubiano, Lucia; Saravia, Jaime; Suarez, Martha; Solano, María Elena; Torres, Hernan; Velásquez, Gloria.
Med. U.P.B ; 12(2): 135-146, oct.1993.
Artículo en Español | LILACS | ID: lil-694395

Documentos relacionados

  1. <i>Candida</i> meningitis/ventriculitis over a decade. Increased morbidity and length of stay a concern.
  2. Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
  3. Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing.
  4. Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.
  5. Effect of intravaginal gentian violet for acute vaginal candidiasis treated with a single dose oral fluconazole: a randomised controlled trial.
  6. Laboratory-based surveillance of Candida auris in Colombia, 2016-2020.
  7. Perfil epidemiológico de pacientes con diagnóstico de candidiasis ingresados en el Hospital Nacional de Niños Benjamín Bloom en el periodo de enero de 2011 a diciembre de 2015
  8. Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates.
  9. Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections.
  10. [Results of the use of micafungin in newborns].